<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Growing evidence from in vitro studies supports that <z:chebi fb="0" ids="39867">valproic acid</z:chebi> (VPA), an anti-convulsant and mood-stabilizing drug, has neuroprotective effects </plain></SENT>
<SENT sid="1" pm="."><plain>The present study investigated whether VPA reduces brain damage and improves functional outcome in a transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> model of rats </plain></SENT>
<SENT sid="2" pm="."><plain>Subcutaneous injection of VPA (300 mg/kg) immediately after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> followed by repeated injections every 12 h, was found to markedly decrease <z:mpath ids='MPATH_124'>infarct</z:mpath> size and reduce <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced neurological deficit scores measured at 24 and 48 h after ischemic <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>VPA treatment also suppressed <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced neuronal caspase-3 activation in the cerebral cortex </plain></SENT>
<SENT sid="4" pm="."><plain>VPA treatments resulted in a time-dependent increase in acetylated <z:chebi fb="0" ids="15358">histone</z:chebi> H3 levels in the cortex and striatum of both ipsilateral and contralateral brain hemispheres of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) rats, as well as in these brain areas of <z:mpath ids='MPATH_458'>normal</z:mpath>, non-surgical rats, supporting the in vitro finding that VPA is a <z:chebi fb="0" ids="15358">histone</z:chebi> deacetylase (HDAC) inhibitor </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, heat shock protein 70 (HSP70) levels were time-dependently up-regulated by VPA in the cortex and striatum of both ipsilateral and contralateral sides of MCAO rats and in these brain areas of <z:mpath ids='MPATH_458'>normal</z:mpath> rats </plain></SENT>
<SENT sid="6" pm="."><plain>Altogether, our results demonstrate that VPA is neuroprotective in the <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> model and suggest that the protection mechanisms may involve HDAC inhibition and <z:chebi fb="24" ids="50430">HSP</z:chebi> induction </plain></SENT>
</text></document>